[FURL=https://www.industryarc.com/Report/15050/penicillin-streptomycin-market.html]Penicillin and Streptomycin Market[/FURL] size is estimated to reach $2.9 Billion by 2025, growing at a CAGR of 0.7% during the forecast period 2020-2025. Penicillin and Streptomycin are the two Antibiotics that are widely used in treating bacterial infections owing to their powerful combined action against gram-negative bacteria and gram-positive bacteria. Penicillin is used in treating throat infections meningitis, syphilis and other infections. Streptomycin is used in treating Tuberculosis, Mycobacterium avium complex, Plague, Rat-bite fever and other. Key Takeaways
Geographically, Asia-Pacific Penicillin and Streptomycin Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high demand for Penicillin and Streptomycin Market as a pesticide in this region.
Increased demand for new formulation and recent developments made by the key players in a different region of the world are driving the market.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Penicillin and Streptomycin Market report.
Increased food security in different regions and increased usage of Penicillin and Streptomycin Market in treating the different bacterial infections and in cell culture are driving the market during the forecast period 2020-2025.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=15050[/FURL]
Penicillin and Streptomycin Market Segment Analysis - By Geography
Based on Geography the global Penicillin and Streptomycin market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Asia-Pacific had the dominant share of 38.6% in the year 2019 owing to the increased production on Penicillin and Streptomycin, and China is the largest supplier of Penicillin and Streptomycin globally. Asia-Pacific is set to have the fastest growth during the forecast period 2020-2025, owing to the increase in demand of antibiotics.
Penicillin and Streptomycin Market Drivers
Increase in Contagious Disease:
Increase in Investments in R&D:
Penicillin and Streptomycin Market Industry Outlook:
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Penicillin and Streptomycin Market. In 2019, Penicillin and Streptomycin Market share is fragmented by the top ten players present in the market. Penicillin and Streptomycin Market top 10 players are Pfizer, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Lonza AG, Novartis Healthcare, Merck & Co, Dr Reddy Laboratories, Takeda Pharmaceutical Company Ltd., Astellas Pharma Inc., Eli Lilly and company are among the significant players.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.